A widely used procedure for site localization of covalent protein modifications involves proteolysis, partial chromatographic separation of the resulting complex mixture, and tandem mass spectrometry (MS/MS) to identify peptides whose molecular weight (M r ) has been increased appropriately by the modification. As found previously for MS of small molecules, this study shows that protein fragment identification can be greatly simplified by labeling the modification with stable isotopes. Further, the high resolution capabilities of Fourier transform MS make possible the direct identification of CH 3 /CD 3 -labeled peptides without chromatographic separation. Although separate Asp-N, Lys-C, and ␣-chy- Biological activity can be dramatically altered by a small covalent modification in molecular structure (1, 2). To characterize such modifications in small molecules, the sensitivity, speed, and specificity of tandem mass spectrometry (MS/MS) 1 (3-5) provide well recognized advantages over other methods (e.g. Edman, NMR, IR, crystallography) (2, 6, 7). For example, identifying drug metabolites in a complex extract is especially straightforward if a methyl group of the drug molecule has been partially replaced by CD 3 ; even if the mass spectrum contains many molecular ions, any showing isotopic peaks separated by 3 Da are probably those of a metabolite (3, 8, 9) . Further, MS/MS isolation and fragmentation of each isotopically unique ion group can provide information on the label's location in the molecule. Characterizing post-translational or other covalent modifications in large biomolecules is even more challenging (6); the most effective MS methods (4, 10, 11) for proteins of known sequence (amounts as low as 3 ϫ 10 Ϫ14 mol) (10) employ extensive proteolysis, chromatographic fractionation, and MS/MS of the peptide fractions. The masses of the peptides originating from the protein without and with the label can be compared to identify the labeled peptide, followed by its characterization by MS/MS, or all of the labeled protein's peptides can be examined by MS/MS to identify and characterize the labeled peptide. Here this examination is simplified with mixed, preferably isotopically mixed, labels. Further, the chromatographic steps are eliminated by utilizing the Ͼ10 5 MS/MS resolving power of Fourier transform (FT) MS (5, 12, 40) . This is illustrated with identification of the active-site nucleophile of thiaminase I, a 379-amino acid enzyme. Illustrating the potential unique applicability of this methodology, MS/MS data sufficient for identification in the Protein Data Bank (13) have been obtained by ESI/FTMS recently from 10 Ϫ17 mol of a 29-kDa protein (14). Thiaminase I from Bacillus thiaminolyticus catalyzes the degradation of thiamin (vitamin B 1 ; Scheme I, 1) by nucleophilic displacement of its thiazole moiety (15, 17, 41, 42) . Treatment with the suicide substrate 4-amino-6-chloro-2-methylpyrimidine (2) caused the molecular ion mass to increase by the 107 Da expected for a single adduct (16). Fragmentation of these molecular ions gave fragment ions both without and with the 107-Da adduct; the smallest adducted fragment corresponded to the 99-amino acid region Pro 79 to Thr 177 (18).
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(3-5) provide well recognized advantages over other methods (e.g. Edman, NMR, IR, crystallography) (2, 6, 7) . For example, identifying drug metabolites in a complex extract is especially straightforward if a methyl group of the drug molecule has been partially replaced by CD 3 ; even if the mass spectrum contains many molecular ions, any showing isotopic peaks separated by 3 Da are probably those of a metabolite (3, 8, 9) . Further, MS/MS isolation and fragmentation of each isotopically unique ion group can provide information on the label's location in the molecule. Characterizing post-translational or other covalent modifications in large biomolecules is even more challenging (6) ; the most effective MS methods (4, 10, 11) for proteins of known sequence (amounts as low as 3 ϫ 10 Ϫ14 mol) (10) employ extensive proteolysis, chromatographic fractionation, and MS/MS of the peptide fractions. The masses of the peptides originating from the protein without and with the label can be compared to identify the labeled peptide, followed by its characterization by MS/MS, or all of the labeled protein's peptides can be examined by MS/MS to identify and characterize the labeled peptide. Here this examination is simplified with mixed, preferably isotopically mixed, labels. Further, the chromatographic steps are eliminated by utilizing the Ͼ10 5 MS/MS resolving power of Fourier transform (FT) MS (5, 12, 40) . This is illustrated with identification of the active-site nucleophile of thiaminase I, a 379-amino acid enzyme. Illustrating the potential unique applicability of this methodology, MS/MS data sufficient for identification in the Protein Data Bank (13) have been obtained by ESI/FTMS recently from 10 Ϫ17 mol of a 29-kDa protein (14) . Thiaminase I from Bacillus thiaminolyticus catalyzes the degradation of thiamin (vitamin B 1 ; Scheme I, 1) by nucleophilic displacement of its thiazole moiety (15, 17, 41, 42) . Treatment with the suicide substrate 4-amino-6-chloro-2-methylpyrimidine (2) caused the molecular ion mass to increase by the 107 Da expected for a single adduct (16) . Fragmentation of these molecular ions gave fragment ions both without and with the 107-Da adduct; the smallest adducted fragment corresponded to the 99-amino acid region Pro 79 to Thr 177 (18) . 2 MS/MS was unsuccessful in producing the smaller protein fragments required for further localization (16) . Proteolysis should achieve this (4, 6, 7, 10, 11) , but these much smaller fragments must result in a much more complex mixture that would make much more difficult the direct identification of the derivatized peptide without preliminary separation. We show here that this is still possible with high efficiency and accuracy using a mixed covalent label (e.g. substituents H versus CH 3 , CH 3 versus CD 3 on 2) that produces a characteristic signature of neighboring isotopic peaks resolved by FTMS. Other recent MS techniques illustrate related advantages of stable isotope incorporation (19, 20) or depletion (21) in large biomolecules when measured at isotopic resolution. As an unexpected bonus, fragment ion dissociation results in the loss of the covalent label with a sulfur atom, specifically identifying attachment at Cys 113 .
EXPERIMENTAL PROCEDURES
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Synthesis-4-Amino-6-chloro-2,5-dimethylpyrimidine (2-CH 3 ) was synthesized from diethyl methyl malonate in a three-step sequence using the route previously described for the synthesis of 2 (18, 22) . The product was purified by two stages of silica gel chromatography (90:10 chloroform/methanol, 80:20 ethyl acetate/hexanes). 2-CD 3 and 4,5,6-13 C 3 -2 were synthesized in the same manner from diethyl trideuteriomethylmalonate and 13 C 3 -diethylmalonate, respectively (23) . Inactivation and Proteolysis-Thiaminase I (20 l of 2 mg/ml, 40 g) in 50 mM TRIS, 2 mM EDTA, 5% glycerol, pH 7.5, was treated with 1 l of inhibitor (1.0 Ϯ 0.1 mg in 10 l of dimethylformamide) for 16 h at room temperature, dialyzed against 50 mM TRIS, 2 mM EDTA, pH 8.3, overnight, and heated at 80°C for 12 min. Heat-denatured enzyme was incubated with ϳ0.5 g of Asp-N, Lys-C, or ␣-chymotrypsin for 16 and 16 h and 10 and 36 min, respectively, and quenched by the addition of 5 l of acetic acid and freezing.
MS Analysis-Intact protein and crude digests were desalted by loading onto reversed-phase peptide traps (Michrom Bioresources; 0.1 ϫ 1 cm), washed with 1 ml of 1:98:1 CH 3 OH/H 2 O/CH3COOH, and step-eluted with ϳ20 l of 70:28:2 CH 3 OH/H 2 O/CH3COOH. This solution (ϳ5 l) was loaded into either a Nanospray (24) or Picospray (14, 25) ESI emitter with a 1-3 m tip; a voltage of 0.6 -1.2 kV applied to the solution supported ESI and determined the flow rate (ϳ1-50 nl/min). Resulting ions were guided through a heated metal capillary, skimmer, and three radio frequency-only quadrupoles into the ion cell (10 Ϫ9 Torr) of a modified 6-Tesla Finnigan FTMS (26) . Transients were stored as 128 -512 K data sets and analyzed using Odyssey Version 4.0 software. Theoretical isotopic distributions were generated using Isopro Version 2.0 (27) and fit to experimental data by least squares to assign the most abundant isotopic peak and relative ratios of overlapping isotopic distributions. Spectra were calibrated either externally using bovine ubiquitin (M r ϭ 8,564.64-5) or for peptide mixtures, internally, using identified peptides. The mass difference (in units of 1.0034 Da) between the most abundant isotopic peak and the monoisotopic peak is denoted in italics after each M r value. For isotopic labels, the ⌬m values are corrected for isotopic overlaps such as the contribution of 13 C 3 1 H 3 to 12 C 3 2 H 3 . Ion fragmentation utilized nozzle-skimmer (NS) collisional activation during ion introduction (28) or sustained off-resonance irradiation (SORI) for fragmentation in the ion cell (29, 35) .
RESULTS AND DISCUSSION
Recombinant thiaminase I yielded three molecular ions (42, 42, 42, due to N-terminal heterogeneity (extra Ala, Ala-Gly) (16) . Incubation with the suicide substrate 2 (18, 22) increased their masses by 108 Ϯ 1 Da, consistent with the 107-Da mass difference (⌬m) expected for Cl Ϫ release during inactivation of one active site in each of the three enzyme molecules. This spectrum showed the isotopic cluster around 42, 198 Da to be Ͻ5% as abundant as that around 42,305 Da (16), indicating that derivatization was Ͼ95% complete, as confirmed by 2-nitro-5-thiol sulfobenzoate thiol titration (18) . NS dissociation of the multiply charged protein ions from the underivatized enzyme gave 61 different fragment ion masses whose sequence location could be assigned from the corrected DNA-derived sequence (16) . Fragments were identified that represented all parts of the protein, but loss of the covalent label from the molecular ion was not detected.
Data Interpretation Complexity-For active-site location, the NS spectra of the enzyme without (Fig. 1, a and c) and with ( Fig. 1, b and d) its covalently bound label are compared; all three of the molecular ions show that the label causes a 107-Da increase. The identification of fragment ions that do (Fig. 1, a and b) and do not (Fig. 1, c and d) show this increase is illustrated by the y 301 and y 193 ions (30), 3 respectively. However, this comprehensive search for labeled fragments required careful cross-comparison of all isotopic clusters in both spectra; the shifted y 301 23ϩ peaks (Figs. 1, a versus b) represent Ͻ1% of the m/z range recorded. As an example of possible problems, in a spectrum of the original study (Ref. 16 and Fig. 2) , the derivatized y 301 peak at m/z 1,456 is overlapped by a b 77 6ϩ fragment ion. 3 Amide bond cleavage yields b and y ions containing the N or C terminus, respectively. 
Stable Isotope Localization of Biomolecule Modification
In the derivatized sample spectrum (Fig. 1b) , the abundance of the underivatized y 301 ions (33, 355 Da) is Ͻ10% that of the 33,462-Da ions, consistent with the previous evidence for Ͼ95% derivatization (16, 18) .
Unlabeled/Labeled Mixtures-Thiaminase I labeled with 2-CH 3 was mixed 1:1 with the free enzyme to give NS data (not shown) similar to that of the combined Fig. 1, a and b . Now only a single spectrum is needed to identify the modified y 301 by its satellite peak at ϩ121 Da, and the relative abundances of these peaks will be less affected by any NS fragmentation variance of separate measurements. Because the active site is in a region of the molecular ion stable to NS fragmentation, this only narrowed the label location to the 99-amino acid region Pro 79 -Thr 177 (16) (although a modified site in other regions would be well localized by these data, e.g. the region yielding the NS fragment ions b 46 , b 49 , b 50 , b 52 , b 53 ). Thus proteolysis was tried next, as it can cleave protein bonds at specific sites to produce smaller fragments. 4 Mixture of Two Derivatives-The accuracy of measuring a 121-Da mass difference (Ϯ 1 Da) is relatively poor because the masses as well as their mass difference are so large. To make these smaller, thiaminase I was reacted with a 1:1 mixture of 2 and 2-CH 3 and digested with Asp-N. Inspection of the resulting complex spectrum for a pair of peaks of expected ⌬m ϭ 14.016 was ambiguous, although the 3,816.05-2-Da peak (Fig. 2a) corresponds to that calculated for the Asp-N peptide Asp 90 -Gly 122 with a 121.06-Da label (3,816.06-2). The isotopic cluster corresponding to the peptide with the 107-Da label (3,802-2) is at the noise level, indicating at least a 20:1 overall reactivity difference for these suicide substrates.
To avoid such reactivity differences, thiaminase I was labeled with 2 and 2-CH 3 in separate tubes, mixed 1:1, and digested. The resulting mixture gave a complex spectrum containing Ͼ80 isotopic distributions of ϳ40 peptides examined by ESI/FTMS (Fig. 2b) . Now these peaks (3,802.05-2 and 3,816.06-2) are both of sufficient abundance (Fig. 2c) for an accurate measurement of their mass difference. The ⌬m value found, 14.01 Ϯ 0.02 Da (calculated, 14.02 Da), is of far higher accuracy than that of Fig. 1 and strongly supports the dual label assignment. However, recognition of the ⌬m ϭ 14.02-Da label (indicated as "ϩ14") was difficult because the off-resonance SORI excitation (27) activated the lower mass precursor ions to a far greater extent; infrared multiphoton dissociation (31) would be superior in this regard. The correct identification of the internal ion Pro 109 -Phe 118 , also made ambiguous by the low fragment ion abundance from the 3,816.06-2 precursor (Fig. 3,  inset) , would have further restricted the active site.
MS/MS-The
Isotopic Mixture-To minimize differences in substrate reactivity as well as SORI excitation, a 1:2 mixture of 2-CH 3 and 2-CD 3 was reacted with thiaminase I, and the products were digested with Asp-N. The spectrum of this unfractionated digest (Fig. 4a) To localize further the modification site within Asp 90 -Gly 122 , a region with two internal Lys residues, thiaminase I was treated with a 1:1 mixture of 2-CH 3 and 2-CD 3 and digested with Lys-C. The product spectrum indicated 22 peptides of sizes 1 to 8.2 kDa (Fig. 5a) ; of these, the abundance distributions of the isotopic peak groups beginning at 2,600.37 and 2,617.40 Da (Fig. 5b) were highly distinctive with nearly twice the normal number of isotopic peaks. Fitting the abundance ratios to those expected for the CH 3 and CD 3 adducts indicated these to be in 60:40 and 56:44 ratios for the 2,600 and 2,617 peak groups, respectively; any isotope effects are within the Ϯ 10% error in sample preparation. For the two most abundant isotopic peaks of the two clusters, ⌬m ϭ 3.020 and 3.021 and ⌬m ϭ 3.015 and 3. MS/MS of the 2,617.40-0-Da ions gave eight fragment ions, consistent with the Arg 101 -Lys 121 assignment (Fig. 6a) . Of the fragments that exhibited broadened isotopic distributions, the 1,728.96-0 ions (Fig. 6c) corresponding to y 13 localized the modification to the 13-residue region Pro 109 -Lys
121
; the complementary b 8 ion was not labeled. The measured ⌬m values for the two most abundant isotopic peaks of the y 13 are 3.022 and 3.014, and the isotopic abundances correspond to a label ratio of 67:33; differential SORI excitation of the CH 3 -versus the CD 3 -labeled molecular ions could have altered their 56:44 ratio. NH 3 loss occurs from the N-terminal b 7 and b 8 ions but not from y 13 . FIG. 4 . a, spectrum of peptides from an Asp-N digest of thiaminase I that had been labeled with a 1:2 mixture of 2-CH 3 and 2-CD 3 . b, expansion of the circled region in a, with best fits of calculated abundance distributions for labeling with 2-CH 3 (squares) and 2-CD 3 (circles) in a 32:68 ratio. . This simple identification of one out of 70 peptides limits the labeled site to 13 amino acids without assignment of any other peptides to those possible from common chymotryptic cleavages (i.e. C-terminal to Phe, Tyr, Trp, and Leu). Unfortunately, MS/MS of the Gly 107 -Tyr 119 ions gave only one fragment ion cluster displaying the isotopic signature (Fig. 7, inset) 2ϩ ion are consistent with the formation of the 1,573.93-0 Da ion. These reactions all involve loss of the isotopic label (Fig. 6, c versus b) ; the only apparent explanation is that collisional dissociation is causing the Asp 90 -Gly 122 ions to lose (Scheme II) 3a-SH and the Arg 101 -Lys 121 ions to lose 3b-SH. Thus the suicide substrate must be bound to the enzyme through a sulfur linkage, namely a Cys residue; the only one in these peptides is Cys 113 , identifying the modification site exactly. This ion fragmentation in which the suicide substrate is lost with the active-site nucleophile makes possible the identification of a single labeled residue in a 379-amino acid protein using only the spectrum of one enzymatic digest (Fig. 2 or 5 ) and one MS/MS spectrum of its labeled peaks (Fig. 3 or 6 ) and without assigning the many other M r values observed to other peptide products. Another isotopic label, 4,5,6-13 C 3 -2, gave similar results. Lower Performance MS Instrumentation-Without the 10 5 resolving power (RP) capabilities of FTMS, labeled site location in large proteins would be more difficult but still possible in many cases. Quadrupoles can achieve ϳ10 3 RP for MS and SCHEME II. MS/MS spectra, whereas time-of-flight instruments can achieve substantially higher RP for MS spectra but much lower for MS/MS spectra. The charge states of isotopically unresolved peptide ions from ESI would have to be determined by deconvolution (5), although not those of the singly charged ions from matrix-assisted laser desorption ionization (37) . For RP ϭ 10 3 , the Asp 90 -Gly
122
-labeled (⌬m ϭ 3 Da) ions of the Fig. 4 spectrum would form a single peak although broadened versus that of an unlabeled peptide (at RP ϭ 10 3 , each of 4-kDa isotopic peaks will be 4-Da wide at half-height). Even for a label of larger ⌬m, RP ϭ 10 3 would require prior chromatographic separation to identify labeled peaks in more complex proteolysis mixtures (e.g. 70 peptides, Fig. 7 ).
CONCLUSIONS
Successful application of this approach should be possible for many proteins. The covalent label must not be removed completely by the proteolysis or ion fragmentation used, but partial removal that includes a heteroatom of the labeled amino acid (S, N, O) can substantially restrict its location. High resolution and accuracy are valuable to detect multiple site derivatization from the M r shift caused by labeling and to identify with high confidence the ⌬m indicative of the labeled peaks. Isotopic labels minimize reaction rate differences, whereas ion dissociation methods other than SORI minimize m/z discrimination in MS/MS spectra.
ESI/FTMS can obtain MS/MS information from 10 Ϫ17 -mol samples (14) , so that isotopic labeling could make possible active-site localization with orders of magnitude lower sample requirements than current methodology. Application of this technique to nucleotides could be far more specific with only MS/MS dissociation, as ion fragmentation is much more extensive; complete sequence information has been obtained from MS/MS spectra of a 50-mer DNA (38) . Further, for some studies the mixed isotopic labeling could be carried out in the biological system, such as protein oxidation (39) or post-translation phosphorylation or glycosylation in an 18 O-enriched environment.
